Portfolio company
ImmuneSpec
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides immunopeptidomics analysis services to biotechnology and pharmaceutical firms to support vaccine development, immunotherapy research and biotherapeutic immunogenicity risk assessment.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Antogen
Antogen develops immunopeptidomics tools and diagnostic services for pharmaceutical and biotechnology companies to support therapeutic discovery and clinical trial eligibility testing.
Alithea Biotechnology GmbH
This company develops immunopeptidomics software and laboratory services for pharmaceutical, biotechnology and academic organisations developing cancer immunotherapies and vaccines.
immunos
This biotechnology company develops immunomodulatory proteins and HLA-based biologic therapies for pharmaceutical companies and healthcare providers to treat cancer and autoimmune diseases.
Immulus
The company develops manufacturing processes to selectively expand T-cells for drug development for pharmaceutical and biotechnology customers.
Enpicom
This company develops bioinformatics software for immune repertoire sequencing data analysis to assist biotechnology and pharmaceutical firms in antibody discovery and development.
Spectacell
This company develops a label-free single-cell analysis platform for pharmaceutical and biotechnology organisations to measure the performance of immune therapies.
53Biologics
This company provides contract development and manufacturing services for recombinant proteins and plasmid DNA to biotechnology and pharmaceutical firms.
RoukenBio
This company provides immunology and bioassay research services for biopharmaceutical firms to support drug discovery and preclinical development.
